证券简称：赛恩斯 证券代码：688480 赛恩斯环保股份有限公司 投资者关系活动记录表 编号：2024-007 | --- | --- | --- | --- | |------------------|--------------------------|-------------------------------------------------|-------------| | | | | | | | □ | 特定对象调研 □分析师会议 | | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | | | □ 新闻发布会 □路演活动 | | | | 类别 | 现场参观 | | | | | | 其他（请文字说明其他活动内容） 投资者电话交流会 | | | 参与单位名称 | 1 、长江证券及其他投资者 | 7 人 | | | | 2 、东吴证券及其他投资者 | 14 人 | | | 及人员姓名 | 3 、华泰证券及其他投资者 | 8 人 | | | | 1、2024 年 8 月 | 27 日（周二） | 15:00-16:00 | | 时间 | 2、2024 年 8 月 | 28 日（周三） | ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][7]. Core Insights - The company reported a revenue of 356 million yuan for H1 2024, representing a year-on-year growth of 32.68%. The net profit attributable to the parent company reached 115 million yuan, a significant increase of 216.75%. The net profit after deducting non-recurring gains and losses was 54.09 million yuan, up by 64.97% year-on-year. The overall gross margin improved to 37.09%, an increase of 3.74 percentage points compared to H1 2023 [1][3]. Financial Performance Summary - Revenue Breakdown: - Comprehensive solutions: 105 million yuan, down 15.78% year-on-year - Product sales: 117 million yuan, up 109.77% year-on-year - Operational services: 131 million yuan, up 54.08% year-on-year [3]. - Gross Margin Analysis: - Comprehensive solutions: 30.58%, up 7.87 percentage points - Product sales: 45.03%, down 0.27 percentage points - Operational services: 34.73%, up 1.95 percentage points [3]. - Investment Income: - The company achieved investment income of 61.72 million yuan, primarily from the acquisition of Fujian Zijin Reagent Co., which contributed 59.29 million yuan in investment income due to fair value remeasurement [1][3]. Future Earnings Forecast - Projected revenues for 2024-2026 are estimated at 1.192 billion yuan, 1.545 billion yuan, and 1.776 billion yuan, respectively, with corresponding net profits of 212 million yuan, 228 million yuan, and 290 million yuan. The expected growth rates for net profit are 135%, 7%, and 27% for the respective years [5][7]. - The company maintains a competitive advantage and is expected to achieve high growth in performance, justifying the "Buy" rating [4][5].

Investment Rating - The report maintains a "Buy" rating for the company [1][3] Core Views - The company achieved a revenue of 356 million yuan in the first half of 2024, representing a year-on-year growth of 32.68%, and a net profit attributable to shareholders of 115 million yuan, up 216.75% year-on-year [2][3] - The improvement in revenue structure and the increase in gross margin are driven by a higher proportion of product sales and operational service income [2][3] - The acquisition of Zijin Reagent in February 2024 contributed 59.29 million yuan in investment income, enhancing the company's product sales [2][3] Summary by Sections Financial Performance - Total revenue for 2024 is projected to reach 1,154.25 million yuan, with a year-on-year growth of 42.78% [1] - The net profit attributable to shareholders is expected to be 202.13 million yuan in 2024, reflecting a significant increase of 123.78% year-on-year [1] - The company’s EPS is forecasted to be 2.12 yuan per share in 2024, with a P/E ratio of 11.44 [1] Revenue Breakdown - The revenue from operational services increased by 54.1% year-on-year, accounting for 36.88% of total revenue [2] - Product sales, including reagent products and copper extraction agents, saw a substantial increase of 109.8% year-on-year, making up 32.88% of total revenue [2] - The comprehensive solution for heavy metal pollution prevention generated 105 million yuan in revenue, down 15.8% year-on-year, indicating a need for further transformation into product sales and operational services [2] Strategic Developments - The company is deepening its collaboration with Zijin Mining, with related revenue in the first half of 2024 reaching 83 million yuan, a 14.1% increase year-on-year [2] - The implementation of an equity incentive plan aims to motivate core personnel and attract talent, with revenue targets set at 1.1 billion yuan and 1.5 billion yuan for 2024 and 2025, respectively [3]

赛恩斯环保股份有限公司 关于 2024 年"提质增效重回报"行动方案 的半年度评估报告 赛恩斯环保股份有限公司（以下简称"公司"）为发挥上市公司的主体责任， 更好的回报投资者，基于对行业与公司长期发展前景的信心，结合公司发展战 略与 2024 年经营计划，制定公司 2024 年度"提质增效重回报"行动方案（以 下简称"行动方案"）。截至 2024 年 6 月 30 日，行动方案主要举措的落实（进 展）及成效情况如下： 一、公司业务发展情况 2024 年上半年，公司实现营业收入 35,600.71 万元，同比增长 32.68%；利 润总额 12,279.47 万元，归母净利润 11,536.40 万元，分别同比增长 190.28%、 216.75%；截至 2024 年 6 月 30 日，公司资产总额 169,660.07 万元，较年初增 长 13.64%；归属于母公司所有者权益合计 84,534.58 万元，较年初增长 4.11%； 资产负债率为 34.20%。 公司各业务板块经营情况如下： 单位：万元 10,461.61 11,703.92 13,130.46 综合解决方案 产品销售 运营服务 1 / 5 二 ...

[Definitions](index=4&type=section&id=Section%201%20Definitions) This chapter defines professional terms and abbreviations of company entities used in the report, providing a foundation for understanding the content - This chapter defines professional terms and abbreviations of company entities used in the report, including the company and its subsidiaries, major shareholders, business-related terms (e.g., heavy metal wastewater, acid wastewater, hazardous waste), and technical terms (e.g., biological agents, COD), providing a basis for understanding the report content[11](index=11&type=chunk)[13](index=13&type=chunk) [Company Profile and Key Financial Indicators](index=6&type=section&id=Section%202%20Company%20Profile%20and%20Key%20Financial%20Indicators) This section provides an overview of the company's basic information and presents its key financial data and indicators for the reporting period [Company Basic Information](index=6&type=section&id=I.%20Company%20Basic%20Information) Science Environmental Protection Co., Ltd. (Science, stock code 688480) is a high-tech enterprise specializing in heavy metal pollution control, with Gao Weirong as its legal representative and registered office in Changsha, Hunan - Overview of the company's basic information, including name, stock code, legal representative, and address[16](index=16&type=chunk) - The company's shares are listed on the STAR Market of the Shanghai Stock Exchange, with the stock abbreviation "Science" and code 688480[19](index=19&type=chunk) [Key Accounting Data and Financial Indicators](index=7&type=section&id=VI.%20Key%20Accounting%20Data%20and%20Financial%20Indicators) During the reporting period, the company achieved significant performance growth with revenue up 32.68% and net profit attributable to parent company shareholders increasing by 216.75%, primarily due to the acquisition of Zijin Pharmaceutical and growth in product sales and operational services Key Accounting Data for H1 2024 | Key Accounting Data | Current Period (Jan-Jun) | Prior Period | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 356,007,135.48 Yuan | 268,317,661.23 Yuan | 32.68% | | Net Profit Attributable to Parent Company Shareholders | 115,363,959.35 Yuan | 36,421,553.07 Yuan | 216.75% | | Net Profit Attributable to Parent Company Shareholders Excluding Non-recurring Gains and Losses | 54,085,760.29 Yuan | 32,785,115.38 Yuan | 64.97% | | Net Cash Flow from Operating Activities | -881,498.88 Yuan | 27,432,765.14 Yuan | N/A | | **Indicator** | **Current Period End** | **Prior Year End** | **Period-end vs. Prior Year-end Change (%)** | | Net Assets Attributable to Parent Company Shareholders | 1,061,045,770.34 Yuan | 931,793,098.82 Yuan | 13.87% | | Total Assets | 1,696,600,727.45 Yuan | 1,493,018,387.90 Yuan | 13.64% | Key Financial Indicators for H1 2024 | Key Financial Indicators | Current Period (Jan-Jun) | Prior Period | YoY Change (%) | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (Yuan/share) | 1.21 | 0.38 | 218.42% | | Basic EPS Excluding Non-recurring Gains and Losses (Yuan/share) | 0.57 | 0.35 | 62.86% | | Weighted Average Return on Net Assets (%) | 11.59% | 4.09% | increased by 7.50 percentage points | | Weighted Average ROE Excluding Non-recurring Gains and Losses (%) | 5.43% | 3.68% | increased by 1.75 percentage points | | R&D Investment as % of Operating Revenue (%) | 5.73% | 5.92% | decreased by 0.19 percentage points | - Total non-recurring gains and losses for the reporting period amounted to **61.28 million Yuan**, with the primary item being "gains from investment cost of acquiring subsidiaries, associates, and joint ventures being less than the fair value of identifiable net assets of the investee at acquisition," totaling **58.97 million Yuan**, mainly from the acquisition of Zijin Pharmaceutical[29](index=29&type=chunk)[651](index=651&type=chunk) [Management Discussion and Analysis](index=10&type=section&id=Section%203%20Management%20Discussion%20and%20Analysis) This section provides a comprehensive analysis of the company's industry, core businesses, technological advancements, competitive advantages, operational performance, and key risks [Industry and Main Business Overview in the Reporting Period](index=10&type=section&id=I.%20Industry%20and%20Main%20Business%20Overview%20in%20the%20Reporting%20Period) The company's main business is heavy metal pollution control, expanding into the specialty surfactant industry with copper extractants through the acquisition of Zijin Pharmaceutical, operating a "three-in-one" business model encompassing comprehensive solutions, product sales, and operational services - The heavy metal pollution control industry, where the company operates, is still in its development phase, characterized by low market concentration but strict qualification control and high technical entry barriers[32](index=32&type=chunk)[33](index=33&type=chunk) - In February 2024, the company completed the acquisition of Zijin Pharmaceutical, adding copper extractant products and expanding its business into the specialty surfactant sector within the fine chemical industry[32](index=32&type=chunk)[39](index=39&type=chunk) - The company's operating strategy is "three-in-one": utilizing comprehensive heavy metal pollution control solutions as the core, supported by product sales (reagents, copper extractants, integrated equipment) and operational services, forming a mutually reinforcing business structure[43](index=43&type=chunk) [Core Technologies and R&D Progress](index=16&type=section&id=II.%20Core%20Technologies%20and%20R%26D%20Progress) The company's core technologies, focusing on acid wastewater resource utilization and heavy metal wastewater treatment, remain unchanged with several reaching international leading levels, supported by a **28.37% increase in R&D investment** to **20.39 million Yuan** and a portfolio of **107 intellectual property rights** - The company's core technologies include four major series: acid wastewater resource utilization, heavy metal wastewater deep treatment and reuse, arsenic-containing hazardous waste mineralization detoxification, and heavy metal contaminated environment remediation, with several technological achievements rated as internationally leading or advanced[52](index=52&type=chunk)[53](index=53&type=chunk) R&D Investment Overview | Item | Current Period Amount | Prior Period Amount | Change (%) | | :--- | :--- | :--- | :--- | | Total R&D Investment | 20,385,125.12 Yuan | 15,879,713.32 Yuan | 28.37% | | Total R&D Investment as % of Operating Revenue (%) | 5.73% | 5.92% | decreased by 0.19 percentage points | - As of the end of the reporting period, the company cumulatively holds **107 intellectual property rights**, including **54 invention patents**, with **8 new patent applications** and **8 authorized patents** during the period[54](index=54&type=chunk)[55](index=55&type=chunk) - The company has an R&D team of **164 people**, accounting for **14.25%** of the total workforce, with **74.39%** of team members holding a bachelor's degree or higher[63](index=63&type=chunk)[71](index=71&type=chunk) [Core Competitiveness Analysis in the Reporting Period](index=22&type=section&id=III.%20Core%20Competitiveness%20Analysis%20in%20the%20Reporting%20Period) The company's core competitiveness lies in its leading technology, advantageous products like biological agents and copper extractants, "three-in-one" comprehensive service model, strong brand reputation, and high-caliber R&D and management teams - Technology and R&D advantages: The company has overcome technical challenges in acid wastewater resource utilization, deep treatment of heavy metal wastewater, and harmless disposal of arsenic-containing hazardous waste, and possesses multiple national and provincial-level scientific research platforms[64](index=64&type=chunk)[65](index=65&type=chunk) - Product advantages: Products such as biological agents, mineralizing agents, and copper extractants from subsidiary Zijin Pharmaceutical have achieved domestic substitution, broken international monopolies, and offer significant technical and environmental benefits[67](index=67&type=chunk)[68](index=68&type=chunk) - Specialized comprehensive service advantages: The company has established a "three-in-one" operating system for heavy metal pollution control, encompassing comprehensive solutions, product sales, and operational services, providing all-round services to clients[69](index=69&type=chunk) [Discussion and Analysis of Operations](index=24&type=section&id=IV.%20Discussion%20and%20Analysis%20of%20Operations) In H1 2024, the company achieved significant operational growth with **revenue reaching 356 million Yuan** (up **32.68%**) and **net profit attributable to parent company shareholders at 115 million Yuan** (up **216.75%**), driven by the full acquisition of Zijin Pharmaceutical and the completion of its production base project - In February 2024, the company acquired the remaining **61% equity** in Zijin Pharmaceutical for **183 million Yuan**, achieving **100% control**; Zijin Pharmaceutical reported a net profit of **15.09 million Yuan** in H1, a **91.29% increase** year-on-year[76](index=76&type=chunk) - The fundraising investment project "Production Base Construction Project" was completed and reached its intended usable state on June 30, 2024, with new production lines for complete sets of equipment, pressure vessels, and membrane equipment now operational[77](index=77&type=chunk) - The H2 operating plan focuses on three key business directions: heavy metal pollution control, resource utilization, and new materials, while continuously optimizing the "three-in-one" business model and advancing internationalization strategies[79](index=79&type=chunk)[80](index=80&type=chunk) [Risk Factors](index=27&type=section&id=V.%20Risk%20Factors) The company faces significant risks including macroeconomic and policy changes, intensified market competition, customer concentration, technological iteration, key personnel loss, and financial risks such as high accounts receivable and gross margin fluctuations - Industry risks: The environmental protection sector is policy-driven, and changes in policies or reduced regulatory intensity could adversely affect operations; additionally, a promising industry outlook may attract more competitors[90](index=90&type=chunk) - Operational risks: Downstream customers are primarily non-ferrous metal mining, beneficiation, and smelting enterprises, leading to high customer concentration, and significant changes in major customers' operations could adversely impact the company's business[92](index=92&type=chunk) - Financial risks: A large amount of accounts receivable puts pressure on working capital, potentially leading to bad debts if not collected promptly; additionally, gross margins for solution businesses may fluctuate due to project variations[95](index=95&type=chunk) [Key Operating Conditions in the Reporting Period](index=28&type=section&id=VI.%20Key%20Operating%20Conditions%20in%20the%20Reporting%20Period) This section details the financial status and operating results for the reporting period, highlighting synchronized growth in revenue and costs, increased expenses due to higher salaries, significant asset growth from projects and acquisitions, and a **183 million Yuan** investment to fully acquire Zijin Pharmaceutical [Analysis of Financial Statement Item Changes](index=28&type=section&id=1.%20Analysis%20of%20Financial%20Statement%20Related%20Item%20Changes) During the reporting period, the company experienced significant changes in financial statement items, with **revenue up 32.68%** and **costs up 25.23%**, while selling and administrative expenses increased due to higher salaries, and net cash flow from operating activities turned negative Major Financial Statement Item Changes | Item | Current Period Amount (Yuan) | Prior Period Amount (Yuan) | Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 356,007,135.48 | 268,317,661.23 | 32.68% | | Operating Cost | 223,966,039.09 | 178,839,739.54 | 25.23% | | Selling Expenses | 21,446,887.94 | 13,861,299.28 | 54.72% | | Administrative Expenses | 26,999,485.66 | 19,796,158.01 | 36.39% | | Net Cash Flow from Operating Activities | -881,498.88 | 27,432,765.14 | N/A | [Analysis of Assets and Liabilities](index=29&type=section&id=1.%20Assets%20and%20Liabilities) As of the reporting period end, total assets reached **1.70 billion Yuan**, a **13.64% increase**, with significant shifts including a **41.53% decrease in cash** due to acquisitions and investments, and substantial increases in inventory and fixed assets due to uncompleted projects and acquisitions Major Asset and Liability Item Changes | Item Name | Current Period End Amount (Yuan) | Prior Period End Amount (Yuan) | Change (%) | | :--- | :--- | :--- | :--- | | Cash and Cash Equivalents | 315,202,099.62 | 539,099,788.21 | -41.53% | | Inventories | 100,978,964.15 | 32,067,638.89 | 214.89% | | Fixed Assets | 179,750,982.10 | 80,996,051.53 | 121.93% | | Contract Liabilities | 75,708,106.35 | 44,454,263.80 | 70.31% | [Analysis of Investment Status](index=31&type=section&id=(IV)%20Analysis%20of%20Investment%20Status) The most significant investment activity during the reporting period was the **183 million Yuan** acquisition of **61% equity** in Fujian Zijin Mineral Processing Reagent Co., Ltd., achieving full control and generating **59.29 million Yuan** in investment income - During the reporting period, a significant equity investment occurred with the acquisition of **61% equity** in Fujian Zijin Mineral Processing Reagent Co., Ltd. for **183 million Yuan**, achieving **100% control**, and generating an investment gain of **59.29 million Yuan** in the current period[112](index=112&type=chunk) [Analysis of Major Holding and Participating Companies](index=33&type=section&id=(VI)%20Analysis%20of%20Major%20Holding%20and%20Participating%20Companies) The company holds **8 controlling subsidiaries**, including Science Engineering, Zijin Pharmaceutical, and overseas entities, with Science Engineering achieving **14.27 million Yuan** in net profit and the newly acquired Zijin Pharmaceutical reporting **15.09 million Yuan** in net profit, demonstrating strong profitability Operating Performance of Major Holding Subsidiaries H1 2024 (Unaudited) | Subsidiary Name | Net Assets (10,000 Yuan) | Net Profit (10,000 Yuan) | | :--- | :--- | :--- | | Science Engineering | 12,986.82 | 1,426.82 | | Zijin Pharmaceutical | 11,242.05 | 1,508.93 | | Serbia Subsidiary | 1,770.77 | 682.64 | | Australia Subsidiary | 674.88 | 195.92 | | Dongcheng Wastewater | 9,192.65 | 598.37 | [Corporate Governance](index=39&type=section&id=Section%204%20Corporate%20Governance) This section details the company's corporate governance structure, including shareholder meetings, changes in directors, supervisors, senior management, and core technical personnel, as well as the progress of its equity incentive plan [Shareholder Meeting Overview](index=39&type=section&id=I.%20Shareholder%20Meeting%20Overview) During the reporting period, the company held three shareholder meetings, approving key proposals such as the acquisition of Zijin Pharmaceutical equity, the 2023 annual report, profit distribution plan, and election of independent directors - The second extraordinary general meeting of shareholders in 2024 approved the "Proposal on the Acquisition of 61% Equity in Fujian Zijin Mineral Processing Reagent Co., Ltd. and Related Party Transaction"[132](index=132&type=chunk) - The 2023 annual general meeting of shareholders approved 13 proposals, including the "2023 Annual Profit Distribution Plan" and the "Proposal on the Election of Independent Directors for the Third Board of Directors"[132](index=132&type=chunk) [Changes in Directors, Supervisors, Senior Management, and Core Technical Personnel](index=40&type=section&id=II.%20Changes%20in%20Company%20Directors%2C%20Supervisors%2C%20Senior%20Management%2C%20and%20Core%20Technical%20Personnel) During the reporting period, Mr. Xiao Haijun resigned as an independent director, and Mr. Qu Maohui was elected as the new independent director, with no other changes to directors, supervisors, senior management, or core technical personnel - Independent director Xiao Haijun resigned, and Qu Maohui was elected as the new independent director[135](index=135&type=chunk) [Equity Incentive Plan](index=41&type=section&id=IV.%20Company%20Equity%20Incentive%20Plan) During the reporting period, the company advanced its 2023 Restricted Stock Incentive Plan, granting **168,500 reserved restricted shares** to **14 grantees** and completing the vesting registration for **499,512 shares** from the first grant - On April 2, 2024, the company granted **168,500 reserved restricted shares** to **14 grantees** at an exercise price of **13.93 Yuan/share**[137](index=137&type=chunk) - The company completed the share registration for the first vesting period of the 2023 Restricted Stock Incentive Plan's initial grant, with a total of **499,512 shares vested**[137](index=137&type=chunk) [Environmental and Social Responsibility](index=42&type=section&id=Section%205%20Environmental%20and%20Social%20Responsibility) This section outlines the company's environmental protection efforts, including investments, compliance of key polluting subsidiaries, and initiatives to reduce carbon emissions [Environmental Information Overview](index=42&type=section&id=I.%20Environmental%20Information%20Overview) The company invested **5.06 million Yuan** in environmental protection during the reporting period, with key polluting subsidiaries achieving compliant emissions and implementing emergency plans, while also reducing **663 tons of CO2 equivalent** through initiatives like solar power and geothermal heating - During the reporting period, the company's environmental protection investment amounted to **5.06 million Yuan**[140](index=140&type=chunk) - Subsidiaries Hengyang Songen, Ningxiang Dongcheng Wastewater, and Fujian Zijin Pharmaceutical are designated key polluting units, all of which have constructed and operated pollution control facilities as required, developed emergency plans, and achieved compliant emissions during the reporting period[141](index=141&type=chunk)[143](index=143&type=chunk)[146](index=146&type=chunk)[149](index=149&type=chunk)[153](index=153&type=chunk) - The company implemented measures such as photovoltaic power generation, carbon reduction technologies, and geothermal auxiliary heating, reducing carbon dioxide equivalent emissions by **663 tons** during the reporting period[159](index=159&type=chunk) [Significant Matters](index=47&type=section&id=Section%206%20Significant%20Matters) This section covers major events including significant related party transactions, particularly the acquisition of Zijin Pharmaceutical, and the progress of the company's raised funds utilization [Significant Related Party Transactions](index=61&type=section&id=X.%20Significant%20Related%20Party%20Transactions) During the reporting period, the company engaged in significant related party transactions, primarily the **183 million Yuan** acquisition of **61% equity** in Fujian Zijin Mineral Processing Reagent Co., Ltd. from Zijin Mining Group Co., Ltd., alongside ongoing operational transactions for services and procurement - The company acquired **61% equity** in its associate, Fujian Zijin Mineral Processing Reagent Co., Ltd., for **183 million Yuan** from related party Zijin Mining; post-transaction, the company holds **100% equity** in Zijin Pharmaceutical[218](index=218&type=chunk) - The company has ongoing operational related party transactions with Zijin Mining and its subsidiaries; in 2024, estimated sales of goods or services to them are **450 million Yuan**, with **82.70 million Yuan** incurred in the reporting period, and estimated purchases of goods are **15 million Yuan**, with **5.31 million Yuan** incurred[217](index=217&type=chunk) [Progress of Raised Funds Utilization](index=63&type=section&id=XII.%20Explanation%20of%20Progress%20in%20Use%20of%20Raised%20Funds) As of the reporting period end, the company's net proceeds from its IPO totaled **455 million Yuan**, with **122 million Yuan** cumulatively invested in committed projects (a **30.48% progress**), including the completed "Environmental Equipment Production Base Project" and the "R&D Center Expansion Project" at **57.07% completion** Overall Utilization of Raised Funds (Unit: 10,000 Yuan) | Item | Amount | | :--- | :--- | | Net Proceeds from Offering After Issuance Expenses | 45,469.39 | | Total Committed Investment Project Funds | 25,000.00 | | Cumulative Investment as of Reporting Period End | 12,170.64 | | Overall Progress (%) | 30.48% | - The fundraising investment project "Changsha Science Environmental Engineering Technology Co., Ltd. Complete Environmental Equipment Production Base Project" reached its intended usable state on June 30, 2024[226](index=226&type=chunk)[228](index=228&type=chunk) [Share Changes and Shareholder Information](index=68&type=section&id=Section%207%20Share%20Changes%20and%20Shareholder%20Information) This section details changes in the company's share capital due to equity incentives and provides an overview of its shareholder structure, including major shareholders and the actual controller [Share Capital Changes](index=68&type=section&id=I.%20Share%20Capital%20Changes) During the reporting period, the company's total share capital increased by **499,512 shares** to **95,326,179 shares** due to the vesting of the first grant under the 2023 Restricted Stock Incentive Plan - During the reporting period, due to equity incentive vesting, the company's total share capital increased from **94,826,667 shares** to **95,326,179 shares**, with an addition of **499,512 shares**[236](index=236&type=chunk)[237](index=237&type=chunk) [Shareholder Information](index=69&type=section&id=II.%20Shareholder%20Information) As of the reporting period end, the company had **3,449 common stock shareholders**, with Gao Weirong (**25.25%**) and Zijin Mining Zifeng (Xiamen) Investment Partnership (**21.11%**) as the top two shareholders, and Gao Weirong, Gao Liangyun, and Gao Shihui acting in concert as the actual controllers - As of the end of the reporting period, the company had a total of **3,449 common stock shareholders**[238](index=238&type=chunk) Top Ten Shareholders' Shareholding | Shareholder Name | Shares Held at Period End | Proportion (%) | | :--- | :--- | :--- | | Gao Weirong | 24,065,685 | 25.25% | | Zijin Mining Zifeng (Xiamen) Investment Partnership | 20,120,000 | 21.11% | | Gao Liangyun | 6,244,000 | 6.55% | | Tan Xiaolin | 4,080,000 | 4.28% | | Jiang Guomin | 2,819,000 | 2.96% | [Financial Report](index=76&type=section&id=Section%2010%20Financial%20Report) This section presents the company's unaudited financial statements, including balance sheets, income statements, cash flow statements, and statements of changes in owners' equity, along with detailed notes on key items and changes in consolidation scope [Financial Statements](index=76&type=section&id=II.%20Financial%20Statements) This section provides unaudited consolidated and parent company financial statements, showing growth in total assets and net assets, significant increases in revenue and profit, negative cash flows from operating and investing activities, and positive cash flow from financing activities - The consolidated balance sheet shows total assets of **1.70 billion Yuan** and net assets attributable to parent company shareholders of **1.06 billion Yuan** as of the period end[258](index=258&type=chunk)[260](index=260&type=chunk) - The consolidated income statement shows total operating revenue of **356 million Yuan** and net profit of **118 million Yuan** for H1, of which **115 million Yuan** is attributable to parent company shareholders[266](index=266&type=chunk)[267](index=267&type=chunk) - The consolidated cash flow statement shows a net cash outflow from operating activities of **0.88 million Yuan**, a net cash outflow from investing activities of **290 million Yuan**, and a net cash inflow from financing activities of **47.20 million Yuan**[274](index=274&type=chunk)[275](index=275&type=chunk) [Notes to Consolidated Financial Statement Items](index=122&type=section&id=VII.%20Notes%20to%20Consolidated%20Financial%20Statement%20Items) This section provides detailed notes on key consolidated financial statement items, including **315 million Yuan** in cash (with **41.48 million Yuan** restricted), **432 million Yuan** in accounts receivable, a significant increase in inventory, **165 million Yuan** in new goodwill from the Zijin Pharmaceutical acquisition, and a balanced revenue contribution across comprehensive solutions, product sales, and operational services - Cash and cash equivalents at period-end totaled **315 million Yuan**, of which **41.48 million Yuan** was restricted, primarily for bill deposits, letter of guarantee deposits, and time deposits[392](index=392&type=chunk) - Accounts receivable at period-end had a book balance of **484 million Yuan**, with a bad debt provision of **51.42 million Yuan**, resulting in a carrying value of **432 million Yuan**; the top five customers' accounts receivable and contract assets collectively accounted for **25.92%** of the total[405](index=405&type=chunk)[412](index=412&type=chunk) - Due to the acquisition of Fujian Zijin Mineral Processing Reagent Co., Ltd., **165 million Yuan** in goodwill was newly recognized in the current period[463](index=463&type=chunk) Composition of Main Business Revenue (Current Period) | Business Type | Revenue (Yuan) | Cost (Yuan) | | :--- | :--- | :--- | | Heavy Metal Pollution Control Comprehensive Solutions | 104,616,111.48 | 72,619,454.51 | | Product Sales | 117,039,151.77 | 64,336,612.92 | | Operational Services | 131,304,578.55 | 85,707,240.34 | [Changes in Consolidation Scope](index=177&type=section&id=IX.%20Changes%20in%20Consolidation%20Scope) During the reporting period, the company completed a business combination not under common control by acquiring **61% equity** in Fujian Zijin Mineral Processing Reagent Co., Ltd. for **183 million Yuan** on February 4, 2024, resulting in a total merger cost of **300 million Yuan** and recognition of **165 million Yuan** in goodwill - A business combination not under common control occurred in the current period, with the acquisition of **61% equity** in Fujian Zijin Mineral Processing Reagent Co., Ltd. on February 4, 2024, gaining control and including it within the scope of consolidated financial statements[567](index=567&type=chunk) - The total merger cost for this acquisition was **300 million Yuan**, and after deducting the fair value share of identifiable net assets acquired (**135 million Yuan**), **165 million Yuan** in goodwill was recognized[568](index=568&type=chunk)

证券代码：688480 证券简称：赛恩斯 公告编号：2024-040 赛恩斯环保股份有限公司 第三届监事会第十二次会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 赛恩斯环保股份有限公司（以下简称"公司"）第三届监事会第十二次会 议于 2024 年 8 月 23 日以现场及通讯相结合的方式召开，会议召开地点为公司 会议室。本次会议通知于 2024 年 8 月 13 日送达全体监事。会议由监事会主席 姚晗女士主持。会议应到监事 3 人，实到监事 3 人。本次会议的召集和召开、 表决方式、决议内容符合《中华人民共和国公司法》《上海证券交易所科创板 股票上市规则》等相关法律法规、规范性文件及《公司章程》的相关规定，会 议决议合法有效。 二、监事会会议审议情况 （一）审议通过《关于公司 2024 年半年度报告及其摘要的议案》 表决结果：同意 3 票，反对 0 票，弃权 0 票。 具体内容见公司披露于上海证券交易所网站(www.sse.com.cn)的《赛恩斯 环保股份有限公司 2024 年半年 ...

证券代码：688480 证券简称：赛恩斯 公告编号：2024-039 赛恩斯环保股份有限公司 关于 2024 年半年度募集资金存放与实际使用情 况的专项报告 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意赛恩斯环保股份有限公司首次公 开发行股票注册的批复》（证监许可〔2022〕2166号），本公司由主承销商申 万宏源证券承销保荐有限责任公司采用余额包销方式，向社会公众公开发行人 民币普通股（A股）股票2,370.6667万股，发行价为每股人民币19.18元，共计 募集资金45,469.39万元，坐扣承销和保荐费用3,128.04万元后的募集资金为 42,341.35万元，已由主承销商申万宏源证券承销保荐有限责任公司于2022年11 月22日汇入本公司募集资金监管账户。另减除上网发行费、招股说明书印刷费、 申报会计师费、律师费、评估费等与发行权益性证券直接相关的新增外部费用 2,416.87万元后，公司本次募集资金净额为39,924.48万元。上述募集资金到位 情况已经天健会计师事务所（特殊普通合伙）验证，并由其出具《验资报告》 （天健验〔2022〕1-132号）。 截至2024年6月30日，募集资 ...

证券代码：688480 证券简称：赛恩斯 公告编号：2024-038 | 1、出席会议的股东和代理人人数 | 32 | | --- | --- | | 普通股股东人数 | 32 | | 2、出席会议的股东所持有的表决权数量 | 35,748,361 | | 普通股股东所持有表决权数量 | 35,748,361 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的 | 37.5011 | | 比例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例 | 37.5011 | | （%） | | 赛恩斯环保股份有限公司 2024 年第三次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、会议召开和出席情况 （一） 股东大会召开的时间：2024 年 8 月 5 日 （二） 股东大会召开的地点：湖南省长沙市岳麓区学士街道学士路 388 号 公司会议室 （三） 出席会议的普通股股东及其持有表决权数量的情况： （四） 表决方式是否符合《公司法》及 ...

关于赛恩斯环保股份有限公司 2024 年第三次临时股东大会的法律意见书 致：赛恩斯环保股份有限公司 上海市锦天城律师事务所 关于赛恩斯环保股份有限公司 2024 年第三次临时股东大会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 11、12 层 电话：（86）21-20511000 传真：（86）21-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 鉴此，本所律师根据上述法律、法规及规范性文件的要求，按照律师行业公 认的业务标准、道德规范和勤勉尽责精神，现出具法律意见如下： 1 上海市锦天城律师事务所 法律意见书 一、本次股东大会召集人资格及召集、召开的程序 经核查，公司本次股东大会是由公司董事会召集召开。公司董事会于 2024 年 7 月 19 日在上海证券交易所网站（www.sse.com.cn）发布了《赛恩斯环保股 份有限公司关于召开 2024 年第三次临时股东大会的通知》。上述公告列明了本 次股东大会的召开时间、地点、召开方式、会议期限、出席对象、会议议题等事 项，公告刊登的日期距本次股东大会的召开日期已达 15 日。 上海市锦天 ...

证券代码：688480 证券简称：赛恩斯 赛恩斯环保股份有限公司 2024 年第三次临时股东大会会议资料 2024 年 8 月 1 / 11 | 2024 | 年第三次临时股东大会会议须知 3 | | --- | --- | | 2024 | 年第三次临时股东大会会议议程 5 | | 2024 | 年第三次临时股东大会会议议案 6 | | | 议案一、关于部分募投项目结项并将节余募集资金永久补充流动资金的议案 | | | 6 | | | 议案二、关于部分募投项目调整内部投资结构的议案 9 | | | 议案三、关于修订《公司章程》的议案 11 | 一、为确认出席大会的股东或其代理人或其他出席者的出席资格，会议工作 人员将对出席会议者的身份进行必要的核对工作，请被核对者给予配合。 二、请出席大会的股东或其代理人或其他出席者在会议召开前 30 分钟到达 会场办理签到手续，并请按规定出示证券账户卡、身份证、法定代表人/执行事 务合伙人委派代表身份证明书、营业执照复印件（加盖公章）、授权委托书等证 明文件，经验证后方可出席会议。为保证本次大会的严肃性和正常秩序，切实维 护股东的合法权益，务必请出席大会的股东或其代理人或 ...